BeOne Medicines AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US07725L1026
236,00 € ↑2,00 (0,85%)
2026-06-04
AKTIENPREIS
SecurityDE:49BA / BeOne Medicines AG - Depositary Receipt (Common Stock)
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership204,846 shares
Latest Disclosed Value $ 60,833,117
Millennium Management Llc ownership in 49BA / BeOne Medicines AG - Depositary Receipt (Common Stock)

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 204,846 shares of BeOne Medicines AG - Depositary Receipt (Common Stock) (DE:49BA) valued at $50,801,808 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 31,451 shares of BeOne Medicines AG - Depositary Receipt (Common Stock). This represents a change in shares of 551.32% during the quarter. The current value of the position is $48,343,656 USD.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (49BA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:49BA / BeOne Medicines AG - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BEONE MEDICINES SPONSORED ADS 07725L102 204,846 173,395 551.32 60,833 536.66 0.0253
2026-02-17 2025-12-31 13F BEONE MEDICINES SPONSORED ADS 07725L102 31,451 13,602 76.21 9,555 57.13 0.0040
2025-11-14 2025-09-30 13F BEONE MEDICINES SPONSORED ADS 07725L102 17,849 -183,506 -91.14 6,081 -87.52 0.0026
2025-08-14 2025-06-30 13F BEONE MEDICINES SPONSORED ADS 07725L102 201,355 14,445 7.73 48,742 -4.19 0.0235
2025-05-15 2025-03-31 13F BEIGENE SPONSORED ADS 07725L102 186,910 41,147 28.23 50,871 88.95 0.0271
2025-02-14 2024-12-31 13F BEIGENE SPONSORED ADR 07725L102 145,763 88,638 155.16 26,924 109.93 0.0132
2024-11-14 2024-09-30 13F BEIGENE SPONSORED ADR 07725L102 57,125 43,342 314.46 12,825 552.34 0.0061
2024-08-14 2024-06-30 13F BEIGENE SPONSORED ADR 07725L102 13,783 9,063 192.01 1,966 166.40 0.0009
2024-05-15 2024-03-31 13F BEIGENE SPONSORED ADR 07725L102 4,720 -2,604 -35.55 738 -44.09 0.0003
2024-02-14 2023-12-31 13F BEIGENE SPONSORED ADR 07725L102 7,324 -39,783 -84.45 1,321 -84.42 0.0006
2023-11-14 2023-09-30 13F BEIGENE SPONSORED ADR 07725L102 47,107 -63,864 -57.55 8,473 -57.18 0.0043
2023-08-14 2023-06-30 13F BEIGENE SPONSORED ADR 07725L102 110,971 33,253 42.79 19,786 18.12 0.0098
2023-05-15 2023-03-31 13F BEIGENE SPONSORED ADR 07725L102 77,718 46,155 146.23 16,751 141.30 0.0096
2023-02-14 2022-12-31 13F BEIGENE SPONSORED ADR 07725L102 31,563 -16,825 -34.77 6,942 6.41 0.0038
2022-11-14 2022-09-30 13F BEIGENE SPONSORED ADR 07725L102 48,388 12,160 33.57 6,524 11.26 0.0039
2022-08-15 2022-06-30 13F BEIGENE SPONSORED ADR 07725L102 36,228 36,228 5,864 0.0036
2022-05-16 2022-03-31 13F BEIGENE SPONSORED ADR 07725L102 0 -2,447 -100.00 0 -100.00
2022-02-14 2021-12-31 13F BEIGENE SPONSORED ADR 07725L102 2,447 626 34.38 663 0.30 0.0003
2021-11-15 2021-09-30 13F BEIGENE SPONSORED ADR 07725L102 1,821 -2,419 -57.05 661 -54.57 0.0004
2021-08-16 2021-06-30 13F BEIGENE SPONSORED ADR 07725L102 4,240 4,240 1,455 0.0009
2021-05-17 2021-03-31 13F BEIGENE SPONSORED ADR 07725L102 0 -23,997 -100.00 0 -100.00
2021-02-16 2020-12-31 13F BEIGENE SPONSORED ADR 07725L102 23,997 23,997 6,201 0.0045
2020-05-14 2020-03-31 13F BEIGENE SPONSORED ADR 07725L102 0 -70,906 -100.00 0 -100.00
2020-02-14 2019-12-31 13F BEIGENE SPONSORED ADR 07725L102 70,906 70,906 11,753 0.0147
2019-11-14 2019-09-30 13F BEIGENE SPONSORED ADR 07725L102 0 -35,385 -100.00 0 -100.00
2019-08-15 2019-06-30 13F/A-1 BEIGENE SPONSORED ADR 07725L102 35,385 15,417 77.21 4,386 66.39 0.0066
2019-08-14 2019-06-30 13F BEIGENE SPONSORED ADR 07725L102 35,385 15,417 4,386
2019-05-14 2019-03-31 13F BEIGENE SPONSORED ADR 07725L102 19,968 13,276 198.39 2,636 180.72 0.0039
2019-02-15 2018-12-31 13F/A-1 BEIGENE SPONSORED ADR 07725L102 6,692 1,073 19.10 939 -3.00 0.0015
2019-02-14 2018-12-31 13F BEIGENE SPONSORED ADR 07725L102 6,692 939
2018-11-14 2018-09-30 13F BEIGENE SPONSORED ADR 07725L102 5,619 -126,520 -95.75 968 -95.23 0.0012
2018-08-14 2018-06-30 13F BEIGENE SPONSORED ADR 07725L102 132,139 132,139 2,251.65 20,314 1,998.55 0.0265
2018-02-14 2017-12-31 13F BEIGENE SPONSORED ADR 07725L102 0 -3,454 -100.00 0 -100.00
2017-11-14 2017-09-30 13F BEIGENE SPONSORED ADR 07725L102 3,454 3,454 357 0.0005
2017-08-14 2017-06-30 13F BEIGENE SPONSORED ADR 07725L102 0 -14,061 -100.00 0 -100.00
2017-05-15 2017-03-31 13F BEIGENE SPONSORED ADR 07725L102 14,061 -86,168 -85.97 515 -83.08 0.0009
2017-02-14 2016-12-31 13F BEIGENE SPONSORED ADR 07725L102 100,229 100,229 612.82 3,043 490.87 0.0064
2016-11-14 2016-09-30 13F BEIGENE SPONSORED ADR 07725L102 0 -20,684 -100.00 0 -100.00
2016-08-15 2016-06-30 13F BEIGENE SPONSORED ADR 07725L102 20,684 -43,403 -67.73 616 -67.20 0.0014
2016-05-16 2016-03-31 13F BEIGENE SPONSORED ADR 07725L102 64,087 64,087 1,878 0.0047
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BEONE MEDICINES SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-17 2025-12-31 13F BEONE MEDICINES SPONSORED ADS Call 20,000 -60.00 6,076 -64.33 n/a n/a n/a
2025-11-14 2025-09-30 13F BEONE MEDICINES SPONSORED ADS Call 50,000 17,035 n/a n/a n/a
2024-02-14 2023-12-31 13F BEIGENE SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F BEIGENE SPONSORED ADR Call 23,800 4,281 n/a n/a n/a
2022-08-15 2022-06-30 13F BEIGENE SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F BEIGENE SPONSORED ADR Call 16,000 60.00 3,018 11.41 n/a n/a n/a
2022-02-14 2021-12-31 13F BEIGENE SPONSORED ADR Call 10,000 2,709 n/a n/a n/a
2020-08-14 2020-06-30 13F BEIGENE SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-14 2020-03-31 13F BEIGENE SPONSORED ADR Call 50,000 6,156 n/a n/a n/a
2020-02-14 2019-12-31 13F BEIGENE SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-14 2019-09-30 13F BEIGENE SPONSORED ADR Call 50,000 6,123 n/a n/a n/a
2019-08-15 2019-06-30 13F/A BEIGENE SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-14 2019-03-31 13F BEIGENE SPONSORED ADR Call 21,900 2,891 n/a n/a n/a
2018-08-14 2018-06-30 13F BEIGENE SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F BEIGENE SPONSORED ADR Call 20,000 3,360 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BEONE MEDICINES SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-17 2025-12-31 13F BEONE MEDICINES SPONSORED ADS Put 20,000 -60.00 6,076 -64.33 n/a n/a n/a
2025-11-14 2025-09-30 13F BEONE MEDICINES SPONSORED ADS Put 50,000 17,035 n/a n/a n/a
2020-05-14 2020-03-31 13F BEIGENE SPONSORED ADR Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F BEIGENE SPONSORED ADR Put 25,000 4,144 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.